Russell Investments Group’s Kestra Medical Technologies KMTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.9K Sell
1,552
-11
-0.7% -$259 ﹤0.01% 3484
2025
Q4
$41.5K Buy
1,563
+474
+44% +$12.2K ﹤0.01% 3368
2025
Q3
$25.9K Sell
1,089
-22,113
-95% -$395K ﹤0.01% 3517
2025
Q2
$385K Buy
23,202
+4,859
+26% +$106K ﹤0.01% 2442
2025
Q1
$457K Buy
+18,343
New +$421K ﹤0.01% 2327

Other funds holding KMTS

Russell Investments Group's KMTS Position: Q1 2026 in Review

Russell Investments Group reduced its Kestra Medical Technologies (KMTS) stake by 0.7% in Q1 2026, selling an estimated $259 and leaving 1,552 shares worth $30.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3484.

Russell Investments Group first reported a position in KMTS in Q1 2025 and has held it in 5 quarters since. The position peaked at $457K in Q1 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Russell Investments Group held 1,552 shares of Kestra Medical Technologies worth $30.9K as of Q1 2026.
  • Russell Investments Group sold 11 Kestra Medical Technologies shares in Q1 2026, an estimated $259.
  • Kestra Medical Technologies made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #3484 holding.
  • Russell Investments Group first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 5 quarters since.
  • Russell Investments Group's Kestra Medical Technologies position peaked at $457K in Q1 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.